Skip to main content
. 2020 Nov 3;12(11):3238. doi: 10.3390/cancers12113238

Figure 3.

Figure 3

Overall survival according to FAP intensity in fibroblasts (A) and CD8a density (D) in the tumor center in the Nordic adjuvant trial. Overall survival for FAP intensity in patients expressing low levels of CD8a density (B) and high levels of CD8a density (C) and for CD8a density in patients expressing low levels of FAP intensity (E) and high levels of FAP intensity (F).